Declan Smyth Sells 1,112 Shares of Integer Holdings Co. (ITGR) Stock
Integer Holdings Co. (NYSE:ITGR) insider Declan Smyth sold 1,112 shares of Integer stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $49,917.68. Following the completion of the sale, the insider now owns 11,656 shares in the company, valued at $523,237.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of Integer Holdings Co. (NYSE:ITGR) traded up $1.00 during trading hours on Friday, hitting $45.85. 142,646 shares of the company’s stock were exchanged, compared to its average volume of 143,225. Integer Holdings Co. has a 1-year low of $29.00 and a 1-year high of $55.20. The stock has a market cap of $1,420.00, a PE ratio of 71.64, a P/E/G ratio of 0.95 and a beta of 1.07. The company has a quick ratio of 1.37, a current ratio of 2.58 and a debt-to-equity ratio of 1.95.
Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.82 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.04. Integer had a net margin of 1.42% and a return on equity of 11.22%. The business had revenue of $363.31 million during the quarter, compared to analysts’ expectations of $354.83 million. During the same period last year, the company posted $0.83 EPS. The business’s revenue was up 4.8% on a year-over-year basis. equities research analysts forecast that Integer Holdings Co. will post 2.62 earnings per share for the current year.
ITGR has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Integer from a “sell” rating to a “buy” rating and set a $51.00 price objective for the company in a research note on Wednesday, December 27th. BidaskClub cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. Northcoast Research cut shares of Integer from a “buy” rating to a “neutral” rating in a research note on Monday, October 23rd. They noted that the move was a valuation call. Royal Bank of Canada reissued a “neutral” rating on shares of Integer in a research note on Friday, October 27th. Finally, TheStreet cut shares of Integer from a “b-” rating to a “c+” rating in a research note on Thursday, November 9th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Integer has a consensus rating of “Hold” and an average target price of $51.00.
TRADEMARK VIOLATION WARNING: This news story was first posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/01/05/declan-smyth-sells-1112-shares-of-integer-holdings-co-itgr-stock.html.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.